Nivolumab Plus Ipilimumab in Thyroid Cancer
Clinical trial NCT03246958 · COMPLETED
Trial details
- NCT number
- NCT03246958
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-03
- Primary completion
- 2021-01-21
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.